Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Anorexia 5Neoplasms 4Weight Loss 2Pancreatic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Cachexia 2Breast Neoplasms 2Sleep Initiation and Maintenance Disorders 1Neoplasm Metastasis 1Malnutrition 1Lung Neoplasms 1Head and Neck Neoplasms 1Depressive Disorder, Major 1Depression 1Body Weight 1Anorexia Nervosa with Significantly Low Body Weight 1Advanced Cancer 1

Interventions

Therapeutics 28Psychiatric Rehabilitation 21Surveys and Questionnaires 14Cognitive Behavioral Therapy 12Psilocybin 8Methods 8Ketamine 8Early Intervention, Educational 8Saline Solution 7Yoga 6Mindfulness-Based Cognitive Therapy 6Interviews as Topic 6Esketamine 6Psychosocial Intervention 5Mindfulness 5Escitalopram 5Behavior Therapy 5Methylphenidate 4Exercise Therapy 4Exercise 4Educational Status 4Counseling 4Control Groups 4Acupuncture Therapy 4Standard of Care 3Psychotherapy 3Palliative Care 3Niacin 3Mindfulness-Based Stress Reduction 3Melatonin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Depression × Mirtazapine × Clear all
NCT02650544 2016-01-08

Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression

Sun Yat-sen University

Phase 2 Unknown
236 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Depression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡